MCK up +0.67% percent right now. $MCK High is at 203.11 and

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
MCK up +0.67% percent right now. $MCK High is at 203.11 and the Low 200.16 with current volume of 311,493.

Recent News posted below.

MCK Mckesson Corp Recent Headline News

Earnings Look Back: McKesson Is Down 0.9% Since Reporting Quarterly Results 1 Week Ago (MCK)
Comtex SmarTrend(R) - Mon Nov 10, 9:02AM CST
13 days ago, on October 28th, 2014, McKesson (NYSE:MCK) reported its earnings. Analysts, on average, expected earnings of $2.73 per share on sales of $43.0 billion. The company actually reported EPS of $2.79 on sales of $44.8 billion, beating EPS estimates by $0.06 and beating revenue estimates by $1.8 billion. Since the company's report, shares of McKesson have fallen from $201.20 to $199.32, representing a loss of 0.9% in the past 13 days.
MCK: 202.20 (+0.92)

Recognitions, Financial Results, and Participation in Upcoming Conferences - Research Reports on Vodafone, Zulily, Starbucks, McKesson and Thermo Fisher
PR Newswire - Mon Nov 10, 7:35AM CST
Today, Analysts Review released its research reports regarding Vodafone Group Plc (NASDAQ: VOD), Zulily Inc. (NASDAQ: ZU), Starbucks Corporation (NASDAQ: SBUX), McKesson Corporation (NYSE: MCK) and Thermo Fisher Scientific Inc. (NYSE: TMO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7814-100free.
SBUX: 77.74 (+0.09), MCK: 202.20 (+0.92), TMO: 117.62 (+0.77), VOD: 34.68 (+1.66), ZU: 29.25 (+0.42)

Is CVS Health's "Tobacco-Tax" Brilliant or Stupid?
Todd Campbell, The Motley Fool - Motley Fool - Sun Nov 09, 8:44AM CST
Source: CVS Health Supporters are heralding CVS Health 's decision to create narrow pharmacy networks that penalize tobacco users as a brilliant move, but detractors think it may alienate customers. Both sides have valid arguments, but I...
ESRX: 77.79 (-0.20), CTRX: 47.87 (-0.15), MCK: 202.20 (+0.92), CVS: 89.70 (+0.51), WAG: 67.24 (-0.54), RAD: 5.51 (+0.05)

Watch for McKesson to Potentially Rebound After Falling 1.65% Yesterday
Comtex SmarTrend(R) - Fri Nov 07, 4:01PM CST
McKesson (NYSE:MCK) traded in a range yesterday that spanned from a low of $198.19 to a high of $202.17. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $200.45 on volume of 880,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MCK: 202.20 (+0.92)

McKesson Falls 1.65% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Nov 07, 4:00PM CST
McKesson (NYSE:MCK) traded in a range yesterday that spanned from a low of $198.19 to a high of $202.17. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $200.45 on volume of 880,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MCK: 202.20 (+0.92)

Cognizant CFO Karen McLaughlin Says Health Care, the Cloud Are Key to Growth
at The Street - Wed Nov 05, 12:10PM CST
Cognizant beat predictions on earnings, but now faces the challenge of becoming a major player in health care IT.
MCK: 202.20 (+0.92), WDAY: 94.24 (-0.92), CTSH: 52.94 (-0.71), HNT: 47.84 (+0.33), CERN: 62.98 (-0.44), CRM: 63.76 (-0.69)

McKesson affirms guidance after FQ2 results
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 1:45PM CST

MCK: 202.20 (+0.92)

5 Things McKesson Corporation's Management Wants You to Know
Keith Speights, The Motley Fool - Motley Fool - Thu Oct 30, 5:23PM CDT
Now that the dust has settled after McKesson Corporation 's second-quarter financial results were announced on Tuesday, it's time to look past the numbers. Yes, McKesson beat expectations for earnings and revenue -- but the real story is what's...
MCK: 202.20 (+0.92), GILD: 108.11 (+1.09), RAD: 5.52 (+0.06)

AmerisourceBergen Earnings Growth Keeps Accelerating
at Investor's Business Daily - Thu Oct 30, 12:46PM CDT
AmerisourceBergen (ABC) on Thursday topped sales and earnings views in its fiscal fourth quarter, helped by its contract with Walgreen (WAG) and Alliance Boots to provide branded and generic pharmaceutical products. AmerisourceBergen's earnings rose...
ABC: 87.85 (+0.14), MCK: 202.20 (+0.92), CAH: 79.58 (+0.49), WAG: 67.24 (-0.54)

AmerisourceBergen Beats on Q4 Earnings, Guides Well - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 10:28AM CDT
AmerisourceBergen Corp. (ABC) posted earnings of $1.10 per share in the fourth quarter of fiscal 2014 (ended Sep 30, 2014), which beat the Zacks Consensus Estimate of $1.05.
ABC: 87.85 (+0.14), MCK: 202.20 (+0.92), CAH: 79.58 (+0.49), WAG: 67.24 (-0.54)

Quarterly Earnings, Dividend Declarations, and Transaction Update - Research Reports on UPS, McKesson, Starwood, Family Dollar and Buffalo Wild Wings
PR Newswire - Thu Oct 30, 8:30AM CDT
Today, Analysts Review released its research reports regarding United Parcel Service, Inc. (NYSE: UPS), McKesson Corporation (NYSE: MCK), Starwood Hotels & Resorts Worldwide Inc. (NYSE: HOT), Family Dollar Stores Inc. (NYSE: FDO) and Buffalo Wild Wings Inc. (NASDAQ: BWLD). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7561-100free.
MCK: 202.20 (+0.92), FDO: 78.50 (unch), BWLD: 161.30 (+2.07), UPS: 108.45 (-0.60), HOT: 78.00 (+1.21)

'Overdue' Dividend Increases: Which Streaks Will End?
David Fish - at Seeking Alpha - Thu Oct 30, 4:16AM CDT

SJR: 26.00 (-0.02), CHRW: 71.50 (-0.67), CAG: 34.20 (-0.33), UTX: 108.19 (-0.81), BOBE: 52.35 (-0.35), DV: 49.42 (+0.32), CAE: 12.77 (-0.17), FAST: 44.40 (-0.04), COH: 34.09 (+0.19), MOCO: 16.01 (-0.85), AMAT: 22.50 (-0.13), ORIT: 14.69 (-0.07), NSH: 36.17 (-0.49), RGR: 37.06 (-0.22), DBD: 36.10 (+0.08), MCK: 202.20 (+0.92), PETS: 13.55 (unch), WU: 18.22 (-0.06), TGH: 35.31 (-0.20), ORCL: 40.41 (-0.04), DRI: 55.75 (+1.44), WABC: 50.17 (-0.02), NAUH: 3.02 (-0.03), PETM: 72.33 (-0.41)

McKesson Set to Possibly Rebound After Yesterday's Selloff of 1.37%
Comtex SmarTrend(R) - Wed Oct 29, 3:43PM CDT
McKesson (NYSE:MCK) traded in a range yesterday that spanned from a low of $195.00 to a high of $201.83. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $198.03 on volume of 2.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MCK: 202.20 (+0.92)

Mckesson (MCK) Earnings Report: Q2 2015 Conference Call Transcript
at The Street - Wed Oct 29, 1:26PM CDT
The following Mckesson (MCK) conference call took place on October 28, 2014, 05:00 PM ET. This is a transcript of that earnings call:
MCK: 202.20 (+0.92)

McKesson Beats on Q2 Earnings, Revenues; Keeps Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 10:14AM CDT
McKesson Corporation (MCK) reported fiscal second-quarter 2015 (ended Sep 30, 2014) earnings of $2.79 per share, comfortably beating the Zacks Consensus Estimate of $2.74
AGN: 195.10 (-0.14), MCK: 202.20 (+0.92), CAH: 79.58 (+0.49), CRL: 64.14 (+0.21)

McKesson reports fiscal Q2 2015 GAAP earnings per diluted share from continuing operations of USD2.05
M2 - Wed Oct 29, 4:16AM CDT
Pharmaceuticals company McKesson (NYSE:MCK) revealed on Tuesday its GAAP earnings per diluted share from continuing operations of USD2.05 for the second quarter ended 30 September 2014.
MCK: 202.20 (+0.92)

McKesson's (MCK) CEO John Hammergren on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Oct 28, 8:30PM CDT

MCK: 202.20 (+0.92)

McKesson's Acquisition Powers Drug Revenue Higher
Todd Campbell, The Motley Fool - Motley Fool - Tue Oct 28, 6:14PM CDT
Source: McKesson. McKesson is one of the planet's biggest drug distributors. The company is responsible for delivering roughly one out of every three prescription drugs used in the United States daily and generates more than $138 billion in...
MCK: 202.20 (+0.92), CERN: 63.00 (-0.42)

MCKESSON
at Investor's Business Daily - Tue Oct 28, 5:43PM CDT
MCKESSON (MCK), a drugs distributor, said that its Q3 EPS rose 23% to $2.79, beating by 7 cents. Sales grew 36% to $44.8 bil vs. views for $43 bil. Shares fell 0.8%.
MCK: 202.20 (+0.92)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 57

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 0

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 194

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 165

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 337

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 147

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionary Cookie Storage Solution Enhances Baking Experience

Updated Category News Views 311

Innovative Cookie Storage & Cooling Solution In the realm of baking, having the right tools can make all the difference, especially when it comes to cooling and storing cookies. An inventive individual from New Kent faced frustrations while trying to manage space during the festive baking period. Realizing the need for a solution, this inventor developed the SHERIS COOKIE...

Continue Reading
Alarum Technologies Securities Class Action Update and Analysis

Updated Category News Views 122

Understanding Alarum Technologies Securities Class Action Investors of Alarum Technologies Ltd. (NASDAQ: ALAR) may be facing a significant turning point regarding their investments. A class action lawsuit has been initiated concerning the actions of the company during a specified period. Those affected during this critical time frame have important rights and potential...

Continue Reading
TransCode Therapeutics Schedules Adjourned Special Meeting Updates

Updated Category News Views 211

TransCode Therapeutics Provides Updates on Adjourned Special Meeting TransCode Therapeutics, Inc. (NASDAQ: RNAZ) has announced the adjournment of its Special Meeting, originally scheduled to gather shareholder votes on critical proposals. The meeting will now take place virtually on May 2, allowing shareholders to participate in a flexible and accessible format. The delay...

Continue Reading
Understanding Rep. Mike Kelly's Recent Union Pacific Stock Trading

Updated Category News Views 219

Understanding Rep. Mike Kelly's Recent Stock Activity Recently filed disclosures reveal that Representative Mike Kelly took part in a noteworthy transaction involving Union Pacific, valued between $15,001 and $50,000. This filing was made on December 12, 2024, highlighting the ongoing stock activities of congressional members. As of now, the share price for Union Pacific...

Continue Reading
Cohen & Steers Fund Details: Distribution and Returns Overview

Updated Category News Views 84

Cohen & Steers Total Return Realty Fund, Inc. (NYSE: RFI) stirred the pot back in 2024 when it laid out its managed distribution policy to bolster returns and maintain shareholder interest. The monthly distributions, set at a fixed rate per common share, aimed to give investors a reliable income stream while capitalizing on various investment opportunities throughout the...

Continue Reading